Analysen von Richard Vosser
| 17.04.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 17.04.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 13.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.04.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.04.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 03.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 23.03.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 23.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.03.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 09.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.03.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 07.02.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 03.02.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 01.02.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.01.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 27.01.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 26.01.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 25.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.01.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.11.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 10.11.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 09.11.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 09.11.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 08.11.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 03.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.10.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 31.10.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.10.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 27.10.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 20.10.22 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 07.10.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.10.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 03.10.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.09.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 08.09.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 08.09.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.09.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 31.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 30.08.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 29.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 22.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |